"Genomic Health was founded to take advantage of developments in three areas:

1) Decades of worldwide accumulation of scientific knowledge about cancer pathology at the cellular, molecular and genomic level

2) The continuous development of increasingly sensitive and precise laboratory technologies for quantifying genomic information, and

3) The development of scientific computing technology that permits the storage and analysis of vast amounts of genomic information

It is an exciting fact that progress in each of these three areas continues at a rapid pace. As a result, it is clear that the era of personalized medicine for cancer patients has not only arrived, but has a very bright future."
Since co-founding the company in 2000, Joffre Baker, Ph.D. has served as Co-Founder, Senior Biology Fellow and has overseen the research and development teams behind the breast, colon and prostate cancer programs at Genomic Health. Joffre and his team are currently deploying Next Generation Sequencing technology and its application across all research initiatives in an effort to connect either gene mutations or expression profiles to clinical outcomes and provide additional personalized information to physicians and patients beyond that already available through the use of Oncotype DX®. Prior to cofounding Genomic Health in 2000, Joffre served as Vice President for Research Discovery at Genentech, Inc., a biotechnology company, dedicated to using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. From 1993 to 2000, Joffre oversaw Research Discovery at Genentech, which included the Departments of Cardiovascular Research, Oncology, Immunology, Endocrinology and Pathology. From 1991 to 1993, he served as Genentech’s Director of Cardiovascular Research. Prior to joining Genentech, Joffre was a faculty member in the Department of Biochemistry at the University of Kansas. He holds a Bachelor of Science degree in Biology and Chemistry from the University of California, San Diego and a Ph.D. in Biochemistry from the University of Hawaii. Joffre is the recipient of a NIH (National Institutes of Health) Research Career Development Award (1983 – 1988), and is the author of over 65 publications.

Oncotype DX My Colon Cancer Coach